141 related articles for article (PubMed ID: 16760329)
1. Expression of bovine viral diarrhea virus glycoprotein E2 as a soluble secreted form in a Mammalian cell line.
Donofrio G; Bottarelli E; Sandro C; Flammini CF
Clin Vaccine Immunol; 2006 Jun; 13(6):698-701. PubMed ID: 16760329
[TBL] [Abstract][Full Text] [Related]
2. Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats.
Baxi MK; Deregt D; Robertson J; Babiuk LA; Schlapp T; Tikoo SK
Virology; 2000 Dec; 278(1):234-43. PubMed ID: 11112498
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
[TBL] [Abstract][Full Text] [Related]
4. Induction of virus-neutralizing antibodies by immunization with Rachiplusia nu per os infected with a recombinant baculovirus expressing the E2 glycoprotein of bovine viral diarrhea virus.
Ferrer F; Zoth SC; Calamante G; Taboga O
J Virol Methods; 2007 Dec; 146(1-2):424-7. PubMed ID: 17905447
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bovine Viral Diarrhea Virus Envelope Glycoprotein E2 in Yeast Pichia pastoris and its Application to an ELISA for Detection of BVDV Neutralizing Antibodies in Cattle.
Behera SP; Mishra N; Nema RK; Pandey PD; Kalaiyarasu S; Rajukumar K; Prakash A
J Immunoassay Immunochem; 2015; 36(6):639-54. PubMed ID: 25837831
[TBL] [Abstract][Full Text] [Related]
6. Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.
Liang R; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2007 Aug; 25(32):5994-6006. PubMed ID: 17597267
[TBL] [Abstract][Full Text] [Related]
7. Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines.
Nelson G; Marconi P; Periolo O; La Torre J; Alvarez MA
Vaccine; 2012 Jun; 30(30):4499-504. PubMed ID: 22554468
[TBL] [Abstract][Full Text] [Related]
8. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.
Liang R; van den Hurk JV; Zheng C; Yu H; Pontarollo RA; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2005 Nov; 23(45):5252-62. PubMed ID: 16154245
[TBL] [Abstract][Full Text] [Related]
9. Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.
Couvreur B; Letellier C; Olivier F; Dehan P; Elouahabi A; Vandenbranden M; Ruysschaert JM; Hamers C; Pastoret PP; Kerkhofs P
Vet Res; 2007; 38(6):819-34. PubMed ID: 17727807
[TBL] [Abstract][Full Text] [Related]
10. Immunodominant E2 (gp53) sequences of highly virulent bovine viral diarrhea group II viruses indicate a close resemblance to a subgroup of border disease viruses.
Tijssen P; Pellerin C; Lecomte J; van den Hurk J
Virology; 1996 Mar; 217(1):356-61. PubMed ID: 8599222
[TBL] [Abstract][Full Text] [Related]
11. Variation in E(rns) viral glycoprotein associated with failure of immunohistochemistry and commercial antigen capture ELISA to detect a field strain of bovine viral diarrhea virus.
Gripshover EM; Givens MD; Ridpath JF; Brock KV; Whitley EM; Sartin EA
Vet Microbiol; 2007 Nov; 125(1-2):11-21. PubMed ID: 17582710
[TBL] [Abstract][Full Text] [Related]
12. Truncated E2 of bovine viral diarrhea virus (BVDV) expressed in Drosophila melanogaster cells: a candidate antigen for a BVDV ELISA.
Marzocca MP; Seki C; Giambiagi SM; Robiolo B; Schauer R; Dus Santos MJ; Scodeller EA; La Torre JL; Wigdorovitz A; Grigera PR
J Virol Methods; 2007 Sep; 144(1-2):49-56. PubMed ID: 17512989
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus.
Thomas C; Young NJ; Heaney J; Collins ME; Brownlie J
Vaccine; 2009 Apr; 27(17):2387-93. PubMed ID: 19428855
[TBL] [Abstract][Full Text] [Related]
14. Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.
Wang L; Sunyer JO; Bello LJ
J Virol; 2004 Feb; 78(4):1616-22. PubMed ID: 14747527
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
16. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
Platt R; Coutu C; Meinert T; Roth JA
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
[TBL] [Abstract][Full Text] [Related]
17. Multiple recombinant ELISA for the detection of bovine viral diarrhoea virus antibodies in cattle sera.
Chimeno Zoth S; Taboga O
J Virol Methods; 2006 Dec; 138(1-2):99-108. PubMed ID: 16963129
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus.
Gupta PK; Sharma S; Walunj SS; Chaturvedi VK; Raut AA; Patial S; Rai A; Pandey KD; Saini M
Vet Microbiol; 2005 Jul; 108(3-4):207-14. PubMed ID: 15916870
[TBL] [Abstract][Full Text] [Related]
19. [Expression and characterization of 2 bovine viral diarrhea virus structural proteins (]BVDV)].
Zoth SC; Taboga O; König G; Pereda A; Palma EL; Piccone ME
Rev Argent Microbiol; 2001; 33(1):15-21. PubMed ID: 11407016
[TBL] [Abstract][Full Text] [Related]
20. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD.
Donofrio G; Sartori C; Franceschi V; Capocefalo A; Cavirani S; Taddei S; Flammini CF
Vaccine; 2008 Nov; 26(48):6031-42. PubMed ID: 18812200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
